Stock Chart

KOD

$94.45 -4.07%
Score: 36.3 EXTENDED
LEAPs: SELL $35
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $35
Premium: $8.98
Expiry: Dec 18, 2026
Target: $36
Score: -94

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.79x (vs SPY: 0.8x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About KOD - Kodiak Sciences Inc Common Stock

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Key Statistics

Market Cap $6B

More KOD Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This KOD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track KOD's price movements with trendlines, gamma walls, and key support/resistance levels.